{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T17:56:21Z","timestamp":1770918981174,"version":"3.50.1"},"reference-count":140,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004901","name":"FAPEMIG","doi-asserted-by":"publisher","award":["BPD-00733-22"],"award-info":[{"award-number":["BPD-00733-22"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"FAPEMIG","doi-asserted-by":"publisher","award":["APQ-02736-18"],"award-info":[{"award-number":["APQ-02736-18"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>(1) The primary prostate cancer treatment involves androgen deprivation therapy, with or without chemotherapy. Immunotherapy has emerged as a promising strategy against cancer due to its ability to modulate the immune system, overcome immune evasion, and stimulate the attack on tumor cells. Thus, this review urges an exploration of the underlying mechanisms to validate the efficacy and safety of dendritic cell immunotherapy for prostate cancer treatment. (2) An extensive literature search identified 45 eligible studies in PubMed, Web of Science, SCOPUS, and Embase databases. Phase I and II clinical trials and in vitro studies (PROSPERO registration number CRD42024538296) were analyzed to extract information on patient selection, vaccine preparation, treatment details, and disease progression. (3) Despite significant variability in vaccine development and treatment protocols, vaccines were shown to induce satisfactory immune responses, including T-cell activation, increased CD4 and CD8 cell populations, upregulated expression of HLA-A2 and HLA-DR, enhanced migratory capacity of dendritic cells, and elevated interferon levels. Cytokine responses, particularly involving Interleukin 10 (IL-10) and Interleukin 12 (IL-12), varied across studies. Immunotherapy demonstrated potential by eliciting positive immune responses, reducing PSA levels, and showing an acceptable safety profile. However, side effects such as erythema and fever were observed. (4) The analyzed treatments were well-tolerated, but variability in clinical responses and side effects underscores the need for further research to optimize the efficacy and safety of this therapeutic approach.<\/jats:p>","DOI":"10.3390\/ijms26104939","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T06:31:27Z","timestamp":1747809087000},"page":"4939","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Efficacy of Using Dendritic Cells in the Treatment of Prostate Cancer: A Systematic Review"],"prefix":"10.3390","volume":"26","author":[{"given":"Helen F. M.","family":"Pacheco","sequence":"first","affiliation":[{"name":"Department of Structural Biology, Federal University of Tri\u00e2ngulo Mineiro, Rua Vig\u00e1rio Carlos, 100, 10 Andar, Uberaba CEP 38025-350, MG, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jhessyka L. F.","family":"Fernandes","sequence":"additional","affiliation":[{"name":"Department of Structural Biology, Federal University of Tri\u00e2ngulo Mineiro, Rua Vig\u00e1rio Carlos, 100, 10 Andar, Uberaba CEP 38025-350, MG, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6530-4684","authenticated-orcid":false,"given":"Fernanda C. R.","family":"Dias","sequence":"additional","affiliation":[{"name":"Department of Structural Biology, Federal University of Tri\u00e2ngulo Mineiro, Rua Vig\u00e1rio Carlos, 100, 10 Andar, Uberaba CEP 38025-350, MG, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina C.","family":"Deus","sequence":"additional","affiliation":[{"name":"Department of Structural Biology, Federal University of Tri\u00e2ngulo Mineiro, Rua Vig\u00e1rio Carlos, 100, 10 Andar, Uberaba CEP 38025-350, MG, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele L.","family":"Ribeiro","sequence":"additional","affiliation":[{"name":"Department of Cell Biology, Histology, and Embryology, Federal University of Uberlandia, Av Maranh\u00e3o, 1783, Uberl\u00e2ndia CEP 38405-318, MG, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e1rcia A.","family":"Michelin","sequence":"additional","affiliation":[{"name":"Department of Structural Biology, Federal University of Tri\u00e2ngulo Mineiro, Rua Vig\u00e1rio Carlos, 100, 10 Andar, Uberaba CEP 38025-350, MG, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4397-4609","authenticated-orcid":false,"given":"Marcos L. M.","family":"Gomes","sequence":"additional","affiliation":[{"name":"Department of Structural Biology, Federal University of Tri\u00e2ngulo Mineiro, Rua Vig\u00e1rio Carlos, 100, 10 Andar, Uberaba CEP 38025-350, MG, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,5,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.eururo.2023.04.021","article-title":"2022 Update on Prostate Cancer Epidemiology and Risk Factors\u2014A Systematic Review","volume":"84","author":"Bergengren","year":"2023","journal-title":"Eur. Urol."},{"key":"ref_2","unstructured":"(2022). World Health Organization Global Health Estimates, World Health Organization."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Sekhoacha, M., Riet, K., Motloung, P., Gumenku, L., Adegoke, A., and Mashele, S. (2022). Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches. Molecules, 27.","DOI":"10.3390\/molecules27175730"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Palecki, J., Bhasin, A., Bernstein, A., Mille, P.J., Tester, W.J., Kelly, W.K., and Zarrabi, K.K. (2024). T-Cell Redirecting Bispecific Antibodies: A Review of a Novel Class of Immuno-Oncology for Advanced Prostate Cancer. Cancer Biol. Ther., 25.","DOI":"10.1080\/15384047.2024.2356820"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1200\/JCO.2017.74.3062","article-title":"Journal of clinical oncology Nivolumab Versus Docetaxel in Previously Treated Patients with Advanced Non-Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057)","volume":"35","author":"Horn","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Hato, L., Vizcay, A., Eguren, I., P\u00e9rez-Gracia, J.L., Rodr\u00edguez, J., G\u00e1llego P\u00e9rez-Larraya, J., Sarobe, P., Inog\u00e9s, S., D\u00edaz de Cerio, A.L., and Santisteban, M. (2024). Dendritic Cells in Cancer Immunology and Immunotherapy. Cancers, 16.","DOI":"10.3390\/cancers16050981"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S1470-2045(21)00152-2","article-title":"Pembrolizumab Alone or Combined with Chemotherapy versus Chemotherapy as First-Line Therapy for Advanced Urothelial Carcinoma (KEYNOTE-361): A Randomised, Open-Label, Phase 3 Trial","volume":"22","author":"Powles","year":"2021","journal-title":"Lancet Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41571-024-00859-1","article-title":"Dendritic Cells as Orchestrators of Anticancer Immunity and Immunotherapy","volume":"21","author":"Wculek","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_9","first-page":"6","article-title":"Dendritic cells as an immunotherapy tool as c\u00e9lulas dendr\u00edticas como ferramenta de imunoterapia","volume":"7","author":"Pacheco","year":"2024","journal-title":"Acta Biol. Bras."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"14565","DOI":"10.1073\/pnas.251140998","article-title":"T Cell Infiltration of the Prostate Induced by Androgen Withdrawal in Patients with Prostate Cancer","volume":"98","author":"Mercader","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2217\/imt.09.43","article-title":"Directing Dendritic Cell Immunotherapy towards Successful Cancer Treatment","volume":"2","author":"Bhardwaj","year":"2010","journal-title":"Immunotherapy"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"eabg2752","DOI":"10.1126\/science.abg2752","article-title":"CD5 Expression by Dendritic Cells Directs T Cell Immunity and Sustains Immunotherapy Responses","volume":"379","author":"He","year":"2023","journal-title":"Science"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1158\/1078-0432.CCR-07-5164","article-title":"Phenotypic Analysis of Prostate-Infiltrating Lymphocytes Reveals T H17 and Treg Skewing","volume":"14","author":"Sfanos","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1053\/hp.2000.6698","article-title":"Metastatic Patterns of Prostate Cancer: An Autopsy Study of 1,589 Patients","volume":"31","author":"Bubendorf","year":"2000","journal-title":"Hum. Pathol."},{"key":"ref_15","first-page":"210","article-title":"Prostate Cancer Immunotherapy: A Review of Recent Advancements with Novel Treatment Methods and Efficacy","volume":"10","author":"Wang","year":"2022","journal-title":"Am. J. Clin. Exp. Urol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Sutherland, S.I.M., Ju, X., Horvath, L.G., and Clark, G.J. (2021). Moving on From Sipuleucel-T: New Dendritic Cell Vaccine Strategies for Prostate Cancer. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.641307"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_18","unstructured":"Higgins, J.P.T., Thomas, J., Chandler, J., Cumpston, M., Li, T., Page, M.J., and Welch, V.A. (2021). Assessing Risk of Bias in a Randomized Trial. Cochrane Handbook for Systematic Reviews of Interventions Version 6.2, Cochrane."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"18192","DOI":"10.18632\/oncotarget.4145","article-title":"Phase I\/II Clinical Trial of Dendritic-Cell Based Immunotherapy (DCVAC\/PCa) Combined with Chemotherapy in Patients with Metastatic, Castration-Resistant Prostate Cancer","volume":"6","author":"Podrazil","year":"2015","journal-title":"Oncotarget"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/s40425-019-0787-6","article-title":"Blood-Derived Dendritic Cell Vaccinations Induce Immune Responses That Correlate with Clinical Outcome in Patients with Chemo-Naive Castration-Resistant Prostate Cancer","volume":"7","author":"Westdorp","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"ref_21","first-page":"2357","article-title":"A Phase I Prospective, Non-Randomized Trial of Autologous Dendritic Cell-Based Cryoimmunotherapy in Patients with Metastatic Castration-Resistant Prostate Cancer. Cancer Immunology","volume":"72","author":"Thomsen","year":"2023","journal-title":"Immunotherapy"},{"key":"ref_22","first-page":"1345","article-title":"Phase I Trial of Antigen-Targeted Autologous Dendritic Cell-Based Vaccine with in Vivo Activation of Inducible CD40 for Advanced Prostate Cancer. Cancer Immunology","volume":"66","author":"Sonpavde","year":"2017","journal-title":"Immunotherapy"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1038\/bjc.2013.494","article-title":"Tumour Cell Lysate-Loaded Dendritic Cell Vaccine Induces Biochemical and Memory Immune Response in Castration-Resistant Prostate Cancer Patients","volume":"109","author":"Reyes","year":"2013","journal-title":"Br. J. Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jcyt.2017.01.007","article-title":"Dendritic Cell Vaccination in Combination with Docetaxel for Patients with Metastatic Castration-Resistant Prostate Cancer: A Randomized Phase II Study","volume":"19","author":"Kongsted","year":"2017","journal-title":"Cytotherapy"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.4049\/jimmunol.166.5.2953","article-title":"Induction of Polyclonal Prostate Cancer-Specific CTL Using Dendritic Cells Transfected with Amplified Tumor RNA","volume":"166","author":"Heiser","year":"2001","journal-title":"J. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1172\/JCI0214364","article-title":"Autologous Dendritic Cells Transfected with Prostate-Specific Antigen RNA Stimulate CTL Responses against Metastatic Prostate Tumors","volume":"109","author":"Heiser","year":"2002","journal-title":"J. Clin. Investig."},{"key":"ref_27","first-page":"2175","article-title":"Priming Tissue-Specific Cellular Immunity in a Phase I Trial of Autologous Dendritic Cells for Prostate Cancer","volume":"6","author":"Burch","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1158\/1078-0432.CCR-16-2199","article-title":"Expression of CD14, IL10, and Tolerogenic Signature in Dendritic Cells Inversely Correlate with Clinical and Immunologic Response to TARP Vaccination in Prostate Cancer Patients","volume":"23","author":"Castiello","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"7150","DOI":"10.4049\/jimmunol.167.12.7150","article-title":"Dendritic Cell-Based Xenoantigen Vaccination for Prostate Cancer Immunotherapy","volume":"167","author":"Fong","year":"2001","journal-title":"J. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Frank, M.O., Kaufman, J., Tian, S., Su\u00e4rez-Far\u00efas, M., Parveen, S., Blach\u00ebre, N.E., Morris, M.J., Slovin, S., Scher, H.I., and Albert, M.L. (2010). Harnessing Naturally Occurring Tumor Immunity: A Clinical Vaccine Trial in Prostate Cancer. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0012367"},{"key":"ref_31","first-page":"89","article-title":"Phase I\/II Trial of Dendritic Cell-Based Active Cellular Immunotherapy with DCVAC\/PCa in Patients with Rising PSA after Primary Prostatectomy or Salvage Radiotherapy for the Treatment of Prostate Cancer. Cancer Immunology","volume":"67","author":"Fucikova","year":"2018","journal-title":"Immunotherapy"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/pros.20404","article-title":"Vaccination of Hormone-Refractory Prostate Cancer Patients with Peptide Cocktail-Loaded Dendritic Cells: Results of a Phase I Clinical Trial","volume":"66","author":"Fuessel","year":"2006","journal-title":"Prostate"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1158\/1078-0432.CCR-1404-02","article-title":"Safety and Biological Activity of Repeated Doses of Recombinant Human Flt3 Ligand in Patients with Bone Scan-Negative Hormone-Refractory Prostate Cancer","volume":"10","author":"Higano","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/pros.20539","article-title":"Immunotherapy of Patients with Hormone-Refractory Prostate Carcinoma Pre-Treated with Interferon-Gamma and Vaccinated with Autologous PSA-Peptide Loaded Dendritic Cells\u2014A Pilot Study","volume":"67","author":"Hildenbrand","year":"2007","journal-title":"Prostate"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.cryobiol.2010.09.004","article-title":"Immunoregulatory Effects of Freeze Injured Whole Tumour Cells on Human Dendritic Cells Using an in Vitro Cryotherapy Model","volume":"61","author":"Ismail","year":"2010","journal-title":"Cryobiology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/sj.bjc.6602761","article-title":"Immunotherapy with Allotumour MRNA-Transfected Dendritic Cells in Androgen-Resistant Prostate Cancer Patients","volume":"93","author":"Mu","year":"2005","journal-title":"Br. J. Cancer"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/(SICI)1097-0045(199612)29:6<371::AID-PROS5>3.0.CO;2-B","article-title":"Phase I Clinical Trial: T-Cell Therapy for Prostate Cancer Using Autologous Dendritic Cells Pulsed With HLA-A020 I-Specific Peptides from Prostate-Specific Membrane Antigen","volume":"29","author":"Murphy","year":"1996","journal-title":"Prostate"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/(SICI)1097-0045(19990401)39:1<54::AID-PROS9>3.0.CO;2-U","article-title":"Phase II Prostate Cancer Vaccine Trial: Report of a Study Involving 37 Patients with Disease Recurrence Following Primary Treatment","volume":"39","author":"Murphy","year":"1999","journal-title":"Prostate"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/(SICI)1097-0045(19990101)38:1<73::AID-PROS9>3.0.CO;2-V","article-title":"Rapid Communication Infusion of Dendritic Cells Pulsed With HLA-A2-Specific Prostate-Specific Membrane Antigen Peptides: A Phase II Prostate Cancer Vaccine Trial Involving Patients With Hormone-Refractory Metastatic Disease","volume":"38","author":"Murphy","year":"1999","journal-title":"Prostate"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/(SICI)1097-0045(20000101)42:1<67::AID-PROS8>3.0.CO;2-I","article-title":"Use of Artificial Neural Networks in Evaluating Prognostic Factors Determining the Response to Dendritic Cells Pulsed With PSMA Peptides in Prostate Cancer Patients","volume":"42","author":"Murphy","year":"2000","journal-title":"Prostate"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/(SICI)1097-0045(20000401)43:1<59::AID-PROS8>3.0.CO;2-D","article-title":"Higher-Dose and Less Frequent Dendritic Cell Infusions With PSMA Peptides in Hormone-Refractory Metastatic Prostate Cancer Patients","volume":"43","author":"Murphy","year":"2000","journal-title":"Prostate"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/sj.pcan.4500694","article-title":"Effective Antigen Cross-Presentation by Prostate Cancer Patients\u2019 Dendritic Cells: Implications for Prostate Cancer Immunotherapy","volume":"7","author":"Orange","year":"2004","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1464-410X.2004.04922.x","article-title":"Dendritic Cell Immunotherapy for Urological Cancers Using Cryopreserved Allogeneic Tumour Lysate-Pulsed Cells: A Phase I\/II Study","volume":"94","author":"Pandha","year":"2004","journal-title":"BJU Int."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/CJI.0000000000000063","article-title":"A Phase I Clinical Trial of CD1c (BDCA-1) + Dendritic Cells Pulsed With HLA-A*0201 Peptides for Immunotherapy of Metastatic Hormone Refractory Prostate Cancer","volume":"38","author":"Prue","year":"2015","journal-title":"J. Immunother."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/(SICI)1097-0045(19980501)35:2<144::AID-PROS8>3.0.CO;2-J","article-title":"Report of Immune Monitoring of Prostate Cancer Patients Undergoing T-Cell Therapy Using Dendritic Cells Pulsed With HLA-A2-Specific Peptides From Prostate-Specific Membrane Antigen (PSMA)","volume":"35","author":"Salgaller","year":"1998","journal-title":"Prostate"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/pros.20266","article-title":"Tumor-Related Immunity in Prostate Cancer Patients Treated with Human Recombinant Granulocyte Monocyte-Colony Stimulating Factor (GM-CSF)","volume":"66","author":"Schwaab","year":"2006","journal-title":"Prostate"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/(SICI)1097-0045(19990601)39:4<291::AID-PROS10>3.0.CO;2-9","article-title":"GM-CSF as a Systemic Adjuvant in a Phase II Prostate Cancer Vaccine Trial","volume":"39","author":"Simmons","year":"1999","journal-title":"Prostate"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3894","DOI":"10.1200\/JCO.2000.18.23.3894","article-title":"Immunotherapy of Hormone-Refractory Prostate Cancer With Antigen-Loaded Dendritic Cells","volume":"18","author":"Small","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.4049\/jimmunol.174.6.3798","article-title":"Telomerase MRNA-Transfected Dendritic Cells Stimulate Antigen-Specific CD8+ and CD4+ T Cell Responses in Patients with Metastatic Prostate Cancer","volume":"174","author":"Su","year":"2005","journal-title":"J. Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1002\/ijc.22097","article-title":"Vaccination of Advanced Prostate Cancer Patients with PSCA and PSA Peptide-Loaded Dendritic Cells Induces DTH Responses That Correlate with Superior Overall Survival","volume":"119","author":"Zeiser","year":"2006","journal-title":"Int. J. Cancer"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/pros.2990270202","article-title":"In Vitro Propagated Dendritic Cells From Prostate Cancer Patients as a Component of Prostate Cancer Lmmunotherapy","volume":"27","author":"Tjoa","year":"1995","journal-title":"Prostate"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1615\/CritRevImmunol.v18.i1-2.120","article-title":"Dendritic Cell-Based Immunotherapy of Prostate Cancer","volume":"18","author":"Salgaller","year":"1997","journal-title":"Crit. Rev. Immunol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/(SICI)1097-0045(19980615)36:1<39::AID-PROS6>3.0.CO;2-6","article-title":"Rapid Communication Evaluation of Phase I\/II Clinical Trials in Prostate Cancer With Dendritic Cells and PSMA Peptides","volume":"36","author":"Tjoa","year":"1998","journal-title":"Prostate"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3322\/canjclin.49.2.117","article-title":"Dendritic Cell-Based Immunotherapy for Prostate Cancer","volume":"49","author":"Tjoa","year":"1999","journal-title":"CA Cancer J. Clin."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/(SICI)1097-0045(19990701)40:2<125::AID-PROS8>3.0.CO;2-Y","article-title":"Follow-Up Evaluation of a Phase II Prostate Cancer Vaccine Trial","volume":"40","author":"Tjoa","year":"1999","journal-title":"Prostate"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/CJI.0b013e31826b20b6","article-title":"Differential Immunologic and MicroRNA Effects of 2 Dosing Regimens of Recombinant Human Granulocyte\/Macrophage Colony Stimulating Factor","volume":"35","author":"Triozzi","year":"2012","journal-title":"J. Immunother."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/pros.20231","article-title":"Dendritic Cells Generated from Patients with Androgen-Independent Prostate Cancer Are Not Impaired in Migration and T-Cell Stimulation","volume":"64","author":"Classon","year":"2005","journal-title":"Prostate"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1007\/s00262-006-0157-3","article-title":"Dendritic Cell-Based Multi-Epitope Immunotherapy of Hormone-Refractory Prostate Carcinoma","volume":"55","author":"Fopp","year":"2006","journal-title":"Cancer Immunology. Immunother."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/pros.20333","article-title":"Numerical and Functional Assessment of Blood Dendritic Cells in Prostate Cancer Patients","volume":"66","author":"Wilkinson","year":"2006","journal-title":"Prostate"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1248\/bpb.b14-00518","article-title":"Survivin and PSMA Loaded Dendritic Cell Vaccine for the Treatment of Prostate Cancer","volume":"38","author":"Xi","year":"2015","journal-title":"Biol. Pharm. Bull."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Steinbach, C., Merchant, A., Zaharie, A.T., Horak, P., Marhold, M., and Krainer, M. (2022). Current Developments in Cellular Therapy for Castration Resistant Prostate Cancer: A Systematic Review of Clinical Studies. Cancers, 14.","DOI":"10.3390\/cancers14225719"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrc4016","article-title":"Emerging Mechanisms of Resistance to Androgen Receptor Inhibitors in Prostate Cancer","volume":"15","author":"Watson","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1172\/JCI80009","article-title":"Therapeutic Cancer Vaccines","volume":"125","author":"Melief","year":"2015","journal-title":"J. Clin. Investig."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00281-018-0691-z","article-title":"Therapeutic Cancer Vaccine: Building the Future from Lessons of the Past","volume":"41","author":"Tran","year":"2019","journal-title":"Semin. Immunopathol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"63","DOI":"10.14740\/wjon1191","article-title":"Epidemiology of Prostate Cancer","volume":"10","author":"Rawla","year":"2019","journal-title":"World J. Oncol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"443","DOI":"10.4049\/jimmunol.1701024","article-title":"Dendritic Cell-Based Cancer Vaccines","volume":"200","author":"Santos","year":"2018","journal-title":"J. Immunol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2217\/ahe.11.56","article-title":"The Aging Immune System and Its Relationship with Cancer","volume":"7","author":"Foster","year":"2011","journal-title":"Aging Health"},{"key":"ref_68","first-page":"133","article-title":"Perspectivas Hist\u00f3ricas Dos Comit\u00eas de \u00c9tica Em Pesquisa No Brasil: Uma Revis\u00e3o Da Literatura Historical Perspectives of Ethics Committees in Research in Brazil: A Literature Review","volume":"11","year":"2020","journal-title":"Sa\u00fade Transforma\u00e7\u00e3o Social\/Health Social Change"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1056\/NEJMsb1616281","article-title":"Prostate Cancer Screening-A Perspective on the Current State of the Evidence","volume":"376","author":"Pinsky","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.clon.2017.08.004","article-title":"Follow-up Care for Survivors of Prostate Cancer\u2014Clinical Management: A Program in Evidence-Based Care Systematic Review and Clinical Practice Guideline","volume":"29","author":"Loblaw","year":"2017","journal-title":"Clin. Oncol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","article-title":"Diagnostic Accuracy of Multi-Parametric MRI and TRUS Biopsy in Prostate Cancer (PROMIS): A Paired Validating Confirmatory Study","volume":"389","author":"Ahmed","year":"2017","journal-title":"Lancet"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrc.2016.16","article-title":"Vaccines for Established Cancer: Overcoming the Challenges Posed by Immune Evasion","volume":"16","author":"Arens","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Ju, H., Xing, W., Yang, J., Zheng, Y., Jia, X., Zhang, B., and Ren, H. (2016). An Effective Cytokine Adjuvant Vaccine Induces Autologous T-Cell Response against Colon Cancer in an Animal Model. BMC Immunol., 17.","DOI":"10.1186\/s12865-016-0172-x"},{"key":"ref_74","first-page":"2A-1","article-title":"Isolation of Mononuclear Cells from Human Cord Blood by Ficoll-Paque Density Gradient","volume":"1","author":"Jaatinen","year":"2007","journal-title":"Curr. Protoc. Stem Cell Biol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.tracli.2019.11.001","article-title":"Characterization of Peripheral Blood Mononuclear Cells Isolated Using Two Kinds of Leukocyte Filters","volume":"27","author":"He","year":"2020","journal-title":"Transfus. Clin. Et. Biol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"7718","DOI":"10.1002\/jcp.27890","article-title":"Serum-Reduced Media Impacts on Cell Viability and Protein Expression in Human Lung Epithelial Cells","volume":"234","author":"Rashid","year":"2019","journal-title":"J. Cell Physiol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00002371-200209000-00007","article-title":"Phenotypical and Functional Characterization of Clinical Grade Dendritic Cells","volume":"25","author":"Eggert","year":"2002","journal-title":"J. Immunother."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"6323","DOI":"10.4049\/jimmunol.171.12.6323","article-title":"The regulatory T cell family: Distinct subsets and their interrelations","volume":"171","author":"Jonuleit","year":"2003","journal-title":"J. Immunol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"e1057673","DOI":"10.1080\/2162402X.2015.1057673","article-title":"Favorable Overall Survival in Stage III Melanoma Patients after Adjuvant Dendritic Cell Vaccination","volume":"5","author":"Bol","year":"2016","journal-title":"Oncoimmunology"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1073\/pnas.96.5.2268","article-title":"Systemic Administration of Interleukin 2 Enhances the Therapeutic Efficacy of Dendritic Cell-Based Tumor Vaccines","volume":"96","author":"Shimizu","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/s41401-020-0415-5","article-title":"Ex Vivo Pulsed Dendritic Cell Vaccination against Cancer","volume":"41","author":"Gu","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.coi.2005.01.004","article-title":"Migration of Dendritic Cell Based Cancer Vaccines: In Vivo Veritas?","volume":"17","author":"Adema","year":"2005","journal-title":"Curr. Opin. Immunol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrclinonc.2014.111","article-title":"Therapeutic Vaccines for Cancer: An Overview of Clinical Trials","volume":"11","author":"Melero","year":"2014","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","article-title":"Pathogen Recognition and Innate Immunity","volume":"124","author":"Akira","year":"2006","journal-title":"Cell"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1002\/embj.201488027","article-title":"Dendritic Cell Maturation: Functional Specialization through Signaling Specificity and Transcriptional Programming","volume":"33","author":"Dalod","year":"2014","journal-title":"EMBO J."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cytogfr.2007.10.004","article-title":"Dendritic Cells and Cytokines in Human Inflammatory and Autoimmune Diseases","volume":"19","author":"Blanco","year":"2008","journal-title":"Cytokine Growth Factor. Rev."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Alcaide, E.G., Krishnarajah, S., and Junker, F. (2021). Dendritic Cell Tumor Vaccination via Fc Gamma Receptor Targeting: Lessons Learned from Pre-Clinical and Translational Studies. Vaccines, 9.","DOI":"10.3390\/vaccines9040409"},{"key":"ref_88","first-page":"571","article-title":"Sindbis Virus\u2014Induced Ocular Immunopathology","volume":"22","author":"Carreras","year":"1982","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"7","DOI":"10.5070\/D32FW0G1XX","article-title":"Delayed type hypersensitivity: Current theories with a historic perspective","volume":"5","author":"Black","year":"1999","journal-title":"Dermatol. Online J."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Vitkin, N., Nersesian, S., Siemens, D.R., and Koti, M. (2019). The Tumor Immune Contexture of Prostate Cancer. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.00603"},{"key":"ref_91","unstructured":"Rezaei, N. (2024). Mechanism of Tumor Growth and Metastasis. Interdisciplinary Cancer Research, Springer."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"e002467","DOI":"10.1136\/jitc-2021-002467","article-title":"Tumor Microenvironment Evaluation Promotes Precise Checkpoint Immunotherapy of Advanced Gastric Cancer","volume":"9","author":"Zeng","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.semcancer.2022.02.017","article-title":"Chemokines and Cytokines: Axis and Allies in Prostate Cancer Pathogenesis","volume":"86","author":"Mughees","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Fay, E.K., and Graff, J.N. (2020). Immunotherapy in Prostate Cancer. Cancers, 12.","DOI":"10.3390\/cancers12071752"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nrclinonc.2017.101","article-title":"The Immune Contexture in Cancer Prognosis and Treatment","volume":"14","author":"Fridman","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature10673","article-title":"Cancer Immunotherapy Comes of Age","volume":"480","author":"Mellman","year":"2011","journal-title":"Nature"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrc.2016.36","article-title":"Mechanism-Driven Biomarkers to Guide Immune Checkpoint Blockade in Cancer Therapy","volume":"16","author":"Topalian","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.4049\/jimmunol.148.6.1652","article-title":"Cd8+ t cells can be primed in vitro to produce IL-4","volume":"148","author":"Seder","year":"1992","journal-title":"J. Immunol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1073\/pnas.96.3.1036","article-title":"Distinct Dendritic Cell Subsets Differentially Regulate the Class of Immune Response in Vivo","volume":"96","author":"Pulendran","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/ni1460","article-title":"Syk- and CARD9-Dependent Coupling of Innate Immunity to the Induction of T Helper Cells That Produce Interleukin 17","volume":"8","author":"Robinson","year":"2007","journal-title":"Nat. Immunol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/nature02238","article-title":"T-Cell Priming by Dendritic Cells in Lymph Nodes Occurs in Three Distinct Phases","volume":"427","author":"Mempel","year":"2004","journal-title":"Nature"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/ni928","article-title":"Dynamics of CD8+ T Cell Priming by Dendritic Cells in Intact Lymph Nodes","volume":"4","author":"Bousso","year":"2003","journal-title":"Nat. Immunol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0952-7915(91)90039-4","article-title":"Signals Arising from Antigen-Presenting Cells","volume":"3","author":"Steinman","year":"1991","journal-title":"Curr. Opin. Immunol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/0952-7915(94)90120-1","article-title":"CD28-B7 Interactions in T-Cel1 Activation","volume":"6","author":"Allison","year":"1994","journal-title":"Curr. Opin. Immunol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jlb.67.1.2","article-title":"CD40-CD40 Ligand","volume":"67","author":"Banchereau","year":"2000","journal-title":"J. Leukoc. Biol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/30989","article-title":"A Conditioned Dendritic Cell Can Be a Temporal Bridge between a CD4 T-Helper and a T-Killer Cell","volume":"393","author":"Ridge","year":"1998","journal-title":"Nature"},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Hernandez, M.E., Soto-Cid, A., Aranda-Abreu, G.E., D\u00edaz, R., Rojas, F., Garcia, L.I., Toledo, R., and Manzo, J. (2007). A Study of the Prostate, Androgens and Sexual Activity of Male Rats. Reprod. Biol. Endocrinol., 5.","DOI":"10.1186\/1477-7827-5-11"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1189\/jlb.0809535","article-title":"CD70 Expression by Dendritic Cells Plays a Critical Role in the Immunogenicity of CD40-Independent, CD4+ T Cell-Dependent, Licensed CD8+ T Cell Responses","volume":"87","author":"Rajapakse","year":"2009","journal-title":"J. Leukoc. Biol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nri1148","article-title":"Co-Stimulatory Members of the TNFR Family: Keys to Effective T-Cell Immunity?","volume":"3","author":"Croft","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1084\/jem.20031111","article-title":"Tumor Rejection Induced by CD70-Mediated Quantitative and Qualitative Effects on Effector CD8+ T Cell Formation","volume":"199","author":"Arens","year":"2004","journal-title":"J. Exp. Med."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1084\/jem.20070176","article-title":"A Subset of Dendritic Cells Induces CD4+ T Cells to Produce IFN-\u03b3 by an IL-12-Independent but CD70-Dependent Mechanism in Vivo","volume":"204","author":"Soares","year":"2007","journal-title":"J. Exp. Med."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1158\/2159-8290.CD-20-0756","article-title":"A Critical Role for Fas-Mediated off-Target Tumor Killing in t-Cell Immunotherapy","volume":"11","author":"Upadhyay","year":"2021","journal-title":"Cancer Discov."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1016\/j.ymthe.2023.02.023","article-title":"CTLA-4 Blockade Induces Tumor Pyroptosis via CD8+ T Cells in Head and Neck Squamous Cell Carcinoma","volume":"31","author":"Wang","year":"2023","journal-title":"Mol. Ther."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-019-1170-y","article-title":"CD8+ T Cells Regulate Tumour Ferroptosis during Cancer Immunotherapy","volume":"569","author":"Wang","year":"2019","journal-title":"Nature"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1097\/01.aids.0000189854.06194.87","article-title":"Aberrant Cortical Neurogenesis in a Pediatric NeuroAIDS Model: Neurotrophic Effects of Growth Hormone","volume":"19","author":"Antony","year":"2005","journal-title":"AIDS"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1600-065X.2008.00616.x","article-title":"Celis E Multiple Roles for CD4 1 T Cells in Anti-Tumor Immune Responses","volume":"222","author":"Kennedy","year":"2008","journal-title":"Immunol. Rev."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1146\/annurev.immunol.22.012703.104533","article-title":"CD40\/CD154 Interactions at the Interface of Tolerance and Immunity","volume":"22","author":"Quezada","year":"2004","journal-title":"Annu Rev. Immunol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1084\/jem.20091921","article-title":"Naive Tumor-Specific CD4+ T Cells Differentiated in Vivo Eradicate Established Melanoma","volume":"207","author":"Xie","year":"2010","journal-title":"J. Exp. Med."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1084\/jem.20150519","article-title":"CRT AM Determines the CD4+ Cytotoxic T Lymphocyte Lineage","volume":"213","author":"Takeuchi","year":"2016","journal-title":"J. Exp. Med."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Matsuzaki, J., Tsuji, T., Luescher, I.F., Shiku, H., Mineno, J., Okamoto, S., Old, L.J., Shrikant, P., Gnjatic, S., and Odunsi, K. (2015). Direct Tumor Recognition by a Human CD4+ T-Cell Subset Potently Mediates Tumor Growth Inhibition and Orchestrates Anti-Tumor Immune Responses. Sci. Rep., 5.","DOI":"10.1038\/srep14896"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1146\/annurev.immunol.23.021704.115843","article-title":"Type I Interferons (\u03b1\/\u03b2) in Immunity and Autoimmunity","volume":"23","author":"Theofilopoulos","year":"2005","journal-title":"Annu. Rev. Immunol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of Type i Interferon Responses","volume":"14","author":"Ivashkiv","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0092-8674(00)81780-8","article-title":"Negative Regulation of PKB\/Akt-Dependent Cell Survival by the Tumor Suppressor PTEN","volume":"95","author":"Stambolic","year":"1998","journal-title":"Cell"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/cmi.2017.30","article-title":"The Functions of Tumor Suppressor PTEN in Innate and Adaptive Immunity","volume":"14","author":"Chen","year":"2017","journal-title":"Cell Mol. Immunol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"7736","DOI":"10.1038\/ncomms8736","article-title":"STAT3 Regulated ARF Expression Suppresses Prostate Cancer Metastasis","volume":"6","author":"Pencik","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"84359","DOI":"10.18632\/oncotarget.12711","article-title":"Inducible Expression of Cancer-Testis Antigens in Human Prostate Cancer","volume":"7","author":"Heninger","year":"2016","journal-title":"Oncotarget"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1016\/j.vaccine.2010.03.007","article-title":"IFN-\u03b3-Mediated Upmodulation of MHC Class I Expression Activates Tumor-Specific Immune Response in a Mouse Model of Prostate Cancer","volume":"28","author":"Martini","year":"2010","journal-title":"Vaccine"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1146\/annurev-immunol-101921-044122","article-title":"Designing Cancer Immunotherapies That Engage T Cells and NK Cells","volume":"41","author":"Kyrysyuk","year":"2023","journal-title":"Annu. Rev. Immunol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"eabe3348","DOI":"10.1126\/sciadv.abe3348","article-title":"Tumor-Specific Cytolytic CD4 T Cells Mediate Immunity against Human Cancer","volume":"7","author":"Cachot","year":"2021","journal-title":"Sci. Adv."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/imm.13114","article-title":"Cancer Immune Escape: MHC Expression in Primary Tumours versus Metastases","volume":"158","author":"Garrido","year":"2019","journal-title":"Immunology"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41423-020-0515-7","article-title":"Allogeneic V\u03b39V\u03b42 T-Cell Immunotherapy Exhibits Promising Clinical Safety and Prolongs the Survival of Patients with Late-Stage Lung or Liver Cancer","volume":"18","author":"Xu","year":"2021","journal-title":"Cell Mol. Immunol."},{"key":"ref_132","first-page":"1720827","article-title":"Regulatory T Cells: Molecular Actions on Effector Cells in Immune Regulation","volume":"1","year":"2016","journal-title":"J. Immunol. Res."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1158\/0008-5472.CAN-11-2499","article-title":"Increased CD8 + T-Cell Function Following Castration and Immunization Is Countered by Parallel Expansion of Regulatory T Cells","volume":"72","author":"Tang","year":"2012","journal-title":"Cancer Res."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.coi.2017.01.002","article-title":"Dendritic Cells in Cancer: The Role Revisited","volume":"45","author":"Veglia","year":"2017","journal-title":"Curr. Opin. Immunol."},{"key":"ref_135","first-page":"4293","article-title":"MiR-221 and MiR-155 Regulate Human Dendritic Cell Development, Apoptosis, and IL-12 Production through Targeting of P27 Kip1, KPC1, and SOCS-1","volume":"117","author":"Lu","year":"2011","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"4862","DOI":"10.1182\/blood-2002-10-3229","article-title":"Induction of CD4+\/CD25+ Regulatory T Cells by Targeting of Antigens to Immature Dendritic Cells","volume":"101","author":"Mahnke","year":"2003","journal-title":"Blood"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1084\/jem.20020732","article-title":"Reversal of Tumor-Induced Dendritic Cell Paralysis by CpG Immunostimulatory Oligonucleotide and Anti-Interleukin 10 Receptor Antibody","volume":"196","author":"Vicari","year":"2002","journal-title":"J. Exp. Med."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.molimm.2023.05.007","article-title":"Plasmacytoid Dendritic Cells: A Dendritic Cell in Disguise","volume":"159","author":"Hornero","year":"2023","journal-title":"Mol. Immunol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/annonc\/mdj138","article-title":"Dacarbazine (DTIC) versus Vaccination with Autologous Peptide-Pulsed Dendritic Cells (DC) in First-Line Treatment of Patients with Metastatic Melanoma: A Randomized Phase III Trial of the DC Study Group of the DeCOG","volume":"17","author":"Schadendorf","year":"2006","journal-title":"Ann. Oncol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1002\/cncr.24429","article-title":"Integrated Data from 2 Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trials of Active Cellular Immunotherapy with Sipuleucel-T in Advanced Prostate Cancer","volume":"115","author":"Higano","year":"2009","journal-title":"Cancer"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/10\/4939\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:36:25Z","timestamp":1760031385000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/10\/4939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,21]]},"references-count":140,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["ijms26104939"],"URL":"https:\/\/doi.org\/10.3390\/ijms26104939","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,21]]}}}